Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer
Phase 2 Unknown
50 enrolled
Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer
Phase 2 Unknown
10 enrolled
V-CHANCE
Phase 2 Unknown
39 enrolled
ATHENA
Phase 2 Unknown
33 enrolled
MorphineGEL
Phase 2 Unknown
106 enrolled
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer
Phase 2 Unknown
20 enrolled
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Phase 2 Unknown
441 enrolled
Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer
Phase 2 Unknown
120 enrolled
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
Phase 2 Unknown
25 enrolled
ERLO-XIB
Phase 2 Unknown
64 enrolled
Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.
Phase 2 Unknown
80 enrolled
Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis
Phase 2 Unknown
200 enrolled
Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1
Phase 2 Unknown
20 enrolled
Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 2 Unknown
53 enrolled
IMPORT
Phase 2 Unknown
316 enrolled
A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma:The POTENTIAL Study
Phase 2 Unknown
38 enrolled
SHINE
Phase 2 Unknown
38 enrolled
SLICER
Phase 2 Unknown
53 enrolled
DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC
Phase 2 Unknown
60 enrolled
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer
Phase 2 Unknown
45 enrolled
SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma
Phase 2 Unknown
25 enrolled
Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
Phase 2 Unknown
40 enrolled
RePASS
Phase 2 Unknown
41 enrolled
Effects of Probiotics in Preventing Oral Mucositis
Phase 2 Unknown
50 enrolled
Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary
Phase 2 Unknown
48 enrolled
SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma
Phase 2 Unknown
30 enrolled
A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers
Phase 2 Unknown
38 enrolled
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
Phase 2 Unknown
180 enrolled
RASS
Phase 2 Unknown
61 enrolled
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Phase 2 Unknown
80 enrolled
Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN
Phase 2 Unknown
144 enrolled
Electrochemotherapy on Head and Neck Cancer
Phase 2 Unknown
25 enrolled
Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT
Phase 2 Unknown
105 enrolled
GS-OROPHARYNX
Phase 2 Unknown
100 enrolled
Apatinib for Advanced Non-squamous Head and Neck Cancer
Phase 2 Unknown
30 enrolled
uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
Phase 2 Unknown
90 enrolled
The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer
Phase 2 Unknown
30 enrolled
Hypoxia Analysis in Head and/or Neck Cancer
Phase 2 Unknown
10 enrolled
Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer
Phase 2 Unknown
76 enrolled
P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer
Phase 2 Unknown
60 enrolled
Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer
Phase 2 Unknown
120 enrolled
Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors
Phase 2 Unknown
180 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
Phase 2 Unknown
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
Phase 2 Unknown
25 enrolled
Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
Phase 2 Unknown
75 enrolled
Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Unknown
Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer
Phase 2 Unknown
35 enrolled
Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Unknown
39 enrolled
Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
Phase 2 Unknown
42 enrolled
Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
Phase 2 Unknown
90 enrolled